World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
31252
World Ranking
13551
National Ranking
6893

Overview

Flavio Vincenti is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on the field of Medicine, with significant contributions to transplantation and immunology. Their work spans various subfields including Transplantation, Immunology, Epidemiology, Infectious Diseases, and Hematology.

The major topics addressed in Vincenti's research include:

  • Renal Transplantation Outcomes and Treatments
  • T-cell and B-cell Immunology
  • Organ Transplantation Techniques and Outcomes
  • Renal Diseases and Glomerulopathies
  • Cytomegalovirus and herpesvirus research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Immune Cell Function and Interaction

Vincenti has published extensively in leading journals related to nephrology and transplantation. Frequent publication venues include:

  • Journal of the American Society of Nephrology
  • American Journal of Transplantation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Nephrology Dialysis Transplantation

Significant recent papers by Vincenti include:

  • Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients, 2023, JAMA
  • Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial, 2021, Journal of the American Society of Nephrology
  • A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection, 2020, Science Translational Medicine
  • Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial, 2020, American Journal of Transplantation
  • Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses, 2023, Cell Reports

Vincenti collaborates frequently with researchers such as Sindhu Chandran, Minnie Sarwal, Tara K. Sigdel, Priyanka Rashmi, and Izabella Damm, contributing to multiple publications with these co-authors.

Best Publications

  • A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

    John D. Pirsch;Joshua Miller;Mark H. Deierhoi;Flavio Vincenti

  • KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary

    Bertram L. Kasiske;Martin G. Zeier;Jeremy R. Chapman;Jonathan C. Craig

  • Interleukin-2-Receptor Blockade With Daclizumab to Prevent Acute Rejection in Renal Transplantation

    F. Vincenti;R. Kirkman;S. Light;G. Bumgardner

  • A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

    F. Vincenti;B. Charpentier;Y. Vanrenterghem;L. Rostaing

  • Costimulation blockade with belatacept in renal transplantation.

    Flavio Vincenti;Christian Larsen;Antoine Durrbach;Thomas Wekerle

  • Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

    Virginia J. Savin;Ram Sharma;Mukut Sharma;Ellen T. Mccarthy

  • Belatacept and Long-Term Outcomes in Kidney Transplantation.

    Flavio Vincenti;Lionel Rostaing;Joseph Grinyo;Kim Rice

  • Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.

    F. Vincenti;S. Friman;E. Scheuermann;L. Rostaing

  • A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)

    A. Durrbach;J. M. Pestana;T. Pearson;F. Vincenti

  • The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

    Atul Humar;Yvon Lebranchu;Flavio Vincenti;Emily A.Emily Blumberg

  • Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.

    Kim Solez;Flavio Vincenti;Ronald S. Filo

  • A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.

    Flavio Vincenti;Stephen C. Jensik;Ronald S. Filo;Joshua Miller

  • The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.

    Michael E. Wachs;William J. Amend;Nancy L. Ascher;Peter N. Bretan

  • Prevalence and management of anemia in renal transplant recipients: a European survey

    Yves Vanrenterghem;Claudio Ponticelli;José Maria Morales;Daniel Abramowicz

  • Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

    F. Vincenti;C. P. Larsen;J. Alberu;B. Bresnahan

  • Deliberate Donor-specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach

    Oscar Salvatierra;Flavio Vincenti;William Amend;Donald Potter

  • Recurrent focal glomerulosclerosis: Natural history and response to therapy

    Mary Artero;Claude Biava;William Amend;Stephen Tomlanovich

  • Guidelines for the treatment and management of new-onset diabetes after transplantation

    Alan Wilkinson;Jaime Davidson;Francesco Dotta;Philip D Home

  • A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients

    F. Vincenti;F. P. Schena;S. Paraskevas;I. A. Hauser

  • Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis.

    Mary L. Artero;Ram Sharma;Virginia J. Savin;Flavio Vincenti

Frequent Co-Authors

Christian P. Larsen
Christian P. Larsen Emory University
Lionel Rostaing
Lionel Rostaing Grenoble Alpes University
Josep M. Grinyó
Josep M. Grinyó University of Barcelona
Klemens Budde
Klemens Budde Charité - University Medicine Berlin
Qizhi Tang
Qizhi Tang University of California, San Francisco
Daniel C. Brennan
Daniel C. Brennan Johns Hopkins University
Jeffrey A. Bluestone
Jeffrey A. Bluestone University of California, San Francisco
Charles S. Craik
Charles S. Craik University of California, San Francisco
Nassim Kamar
Nassim Kamar Paul Sabatier University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in careers related to medicine or healthcare, a variety of flexible online degrees are available. These programs offer diverse pathways for students with different backgrounds and professional goals.

If nutrition and dietetics appeal to you, an online bachelor's in nutrition is a strong foundation for exploring roles in health education, wellness coaching, and public health. For aspiring healthcare leaders and administrators, a cahme accredited online mha programs list provides high-quality master's options tailored for management careers in hospitals or health systems.

Registered nurses aiming to advance their credentials without hands-on clinical requirements can benefit from streamlined online rn to bsn programs without clinical requirements. Nurses seeking doctoral-level education at an accelerated pace should consider accelerated msn to dnp programs for leadership or advanced clinical practice roles.

These pathways offer both flexibility and specialization, supporting the evolving demands of the healthcare field alongside your career or existing commitments.

Best Scientists Citing Flavio Vincenti

Trending Scientists

Recently Published Articles